Recent Analysts’ Ratings Changes for American Healthcare REIT (AHR)

American Healthcare REIT (NYSE: AHR) has recently received a number of price target changes and ratings updates:

• 9/3/2025 – American Healthcare REIT had its “overweight” rating reaffirmed by analysts at Morgan Stanley.
• 8/28/2025 – American Healthcare REIT had its “outperform” rating reaffirmed by analysts at Scotiabank.
• 8/28/2025 – American Healthcare REIT had its price target raised by analysts at Scotiabank from $42.00 to $47.00. They now have a “sector outperform” rating on the stock.
• 8/26/2025 – American Healthcare REIT had its price target raised by analysts at Truist Financial Corporation from $44.00 to $46.00. They now have a “buy” rating on the stock.
• 8/18/2025 – American Healthcare REIT had its price target raised by analysts at Truist Financial Corporation from $38.00 to $44.00. They now have a “buy” rating on the stock.
• 8/13/2025 – American Healthcare REIT had its price target raised by analysts at Royal Bank Of Canada from $39.00 to $45.00. They now have an “outperform” rating on the stock.
• 8/11/2025 – American Healthcare REIT had its price target raised by analysts at JMP Securities from $40.00 to $45.00. They now have a “market outperform” rating on the stock.
• 7/18/2025 – American Healthcare REIT is now covered by analysts at Robert W. Baird. They set an “outperform” rating and a $41.00 price target on the stock.
• 7/17/2025 – American Healthcare REIT was upgraded by analysts at Baird R W to a “strong-buy” rating.

American Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, July 18th. Investors of record on Monday, June 30th were issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend was Monday, June 30th. American Healthcare REIT’s dividend payout ratio is -454.55%.

Insider Activity

In related news, CIO Stefan K.L. Oh sold 3,860 shares of the business’s stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $36.10, for a total transaction of $139,346.00. Following the completion of the transaction, the executive directly owned 95,671 shares in the company, valued at $3,453,723.10. The trade was a 3.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Mark E. Foster sold 3,850 shares of the business’s stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $41.89, for a total value of $161,276.50. Following the transaction, the executive vice president owned 59,100 shares of the company’s stock, valued at approximately $2,475,699. The trade was a 6.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.92% of the stock is owned by insiders.

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.